Clinical Trial

Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer

Study acronym: CYGAS-GC
Recruiting
View on ClinicalTrials.gov →
Summary
The results of the current studies to determine the optimal strategy for metastatic gastric cancer remain contrversial worldwide. Hypothesis: Cytoreductive Gastrectomy After Systemic Therapy will improve survival time for metastasis gastric cancer compared to Systemic Therapy alone.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-06.
Status change: Not Yet Recruiting → Recruiting 2025-08-20
Trial Details
NCT Number NCT06768463
Lead Sponsor University Medical Center Ho Chi Minh City (UMC)
Conditions Metastatic Gastric Cancer, Gastric Cancer, Systemic Therapy, Cytoreductive Gastrectomy
Enrollment 250 participants
Start Date 2025-08-01
Primary Completion 2027-07-10 (estimated)
Study Completion 2027-12-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-27